SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Duke University at SNO 2026

Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website

Duke University brings 30 presentations to SNO 2026 in Philadelphia. Its program centres on immunology, from oncolytic virus therapy and tumor-reactive T cells to CAR-T cells for glioblastoma. Neuropathology and molecular diagnostics also feature, alongside surgical window-of-opportunity trials.

OrganizationSNO 2026 Attendance
Duke University
Durham, NC
Universities & institutes
A research university whose medical school and affiliated centers conduct neuroscience and cancer research, including brain tumor studies.
Talk
Wed Nov 11
3:10–4:35pm
Session
Fri Nov 13
10:15–11:15am
Neuropathology Oral Abstracts Session I
120 ABC, First Floor, Convention Center
Pathology
Talk
Fri Nov 13
10:15–10:22am
Molecular characterization of early progression in IDH-mutant astrocytomas treated with IDH inhibitors
120 ABC, First Floor, Convention Center · Abstract BIOM-60
Biomarkers · Pathology
Talk
Fri Nov 13
11:30–11:33am
Spatial tumor–immune features of primary and recurrent glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract IMMU-43
Immunology
Talk
Fri Nov 13
12:18–12:21pm
A randomized surgical window of opportunity study evaluating fluoxetine and temozolomide in recurrent high-grade glioma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract CTNI-13
Trials
Talk
Fri Nov 13
5–6pm
Poster
Fri Nov 13
7:30–9:30pm
Localized IL-12/anti-PD-1 oncolytic HSV-1 therapy induces CSF immune remodeling inrecurrent glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract CTIM-06
Trials · Immunology
Poster
Fri Nov 13
7:30–9:30pm
A multicenter trial to identify optimal atezolizumab biomarkers in recurrent glioblastoma: the MOAB trial
Exhibit Hall D & E, Second Floor, Convention Center · Abstract CTIM-31
Trials · Immunology
Poster
Fri Nov 13
7:30–9:30pm
Toward Tumor-Reactive TIL Therapy for Glioblastoma: Patient-Matched Autologous Co-Culture Testing of Manufactured TIL Products
Exhibit Hall D & E, Second Floor, Convention Center · Abstract CTIM-32
Trials · Immunology
Poster
Fri Nov 13
7:30–9:30pm
SMARCAL1 inhibition alters immunogenicity in ALT+ high-grade gliomas
Exhibit Hall D & E, Second Floor, Convention Center · Abstract DNAR-05
Tumor biology
Poster
Fri Nov 13
7:30–9:30pm
Profiling alternative splicing across molecular subtypes of atypical teratoid/rhabdoid tumors (ATRT)
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EPCO-07
Pathology
Poster
Fri Nov 13
7:30–9:30pm
Evaluating glioblastoma dendritic cell central nervous system surveillance in aged hosts
Exhibit Hall D & E, Second Floor, Convention Center · Abstract IMMU-48
Immunology
Poster
Fri Nov 13
7:30–9:30pm
Temporal STING heterogeneity in GBM macrophages shapes tumor immunity
Exhibit Hall D & E, Second Floor, Convention Center · Abstract IMMU-57
Immunology
Poster
Fri Nov 13
7:30–9:30pm
Poster
Fri Nov 13
7:30–9:30pm
A case of concurrent glioblastoma and myelin-oligodendrocyte glycoprotein antibody-associated disease
Exhibit Hall D & E, Second Floor, Convention Center · Abstract NCMP-31
Survivorship
Poster
Fri Nov 13
7:30–9:30pm
Spatial transcriptomics reveals myeloid–stromal reorganization and T-cell niche loss at oligodendroglioma recurrence
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TMIC-70
Tumor biology
Plenary
Sat Nov 14
8:30–10am
Part of Plenary III
Award Lecture: Mapping Networks, States, and Vulnerabilities in Glioblastoma
Exhibit Hall C, Second Floor, Convention Center
Talk
Sat Nov 14
11:36–11:39am
Detection of Glioblastoma Tumor-Concordant Variants in Plasma Cell-free DNA during Chemoradiation on a Prospective Pilot Study
Exhibit Hall D & E, Second Floor, Convention Center · Abstract BIOM-05
Biomarkers
Talk
Sat Nov 14
11:36–11:39am
Tumor-intrinsic IFNAR1 signaling drives checkpoint resistance in Glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract IMMU-54
Immunology
Talk
Sat Nov 14
12:12–12:15pm
Talk
Sat Nov 14
12:15–12:18pm
Epigenomic regulation of glioblastoma cell state identity revealed by single-cell multimodal profiling
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EPCO-48
Pathology
Talk
Sat Nov 14
12:18–12:21pm
Talk
Sat Nov 14
12:21–12:24pm
Medulloblastoma Tumoroids for Precision Medicine: Impact of Culture Conditions on Tumor State and Drug Response
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TMOD-30
Therapeutics
Talk
Sat Nov 14
12:27–12:30pm
Session
Sat Nov 14
2:30–3:30pm
Adolescent and Young Adult Oral Abstracts Session
120 ABC, First Floor, Convention Center
Pediatrics
Talk
Sat Nov 14
4:19–4:24pm
Naive T cell organizing vascular assemblies emerge after glioma-directed G207 oncolytic immunovirotherapy
120 ABC, First Floor, Convention Center · Abstract EPCO-21
Pathology · Pediatrics
Talk
Sat Nov 14
5:21–5:28pm
Talk
Sun Nov 15
9:04–9:09am
Spatially informed machine learning predicts glioblastoma recurrence timing from routine histopathology
118 ABC, First Floor, Convention Center · Abstract TMOD-16
Therapeutics · Pathology
Talk
Sun Nov 15
11:14–11:21am
Deciphering glioblastoma tumorigenesis through engineered aneuploidy and cooperating genetic alterations
118 ABC, First Floor, Convention Center · Abstract TMOD-42
Therapeutics · Tumor biology

Explore the full SNO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Philadelphia. Leave your work email and we’ll be in touch.

Privacy

Download the full SNO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Duke University

Tell us what you sell and we’ll find the people at Duke University most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction